PDC and nonpapillary renal cell carcinoma: Additional regulation of iron metabolism is provided by the centrally dysregulated pathway of ccRCC, the von Hippel Lindau (VHL)/proline hydroxylase (PHD)/hypoxia inducible factor-α (HIF-α) axis, which governs the cell response to intracellular oxygen and iron levels [3].